Lymphocyte subpopulations analysis in peripheral blood in polymyalgia rheumatica/giant cell arteritis

Br J Rheumatol. 1993 Aug;32(8):666-70. doi: 10.1093/rheumatology/32.8.666.

Abstract

The phenotypic characteristics of peripheral blood lymphocytes were investigated in 22 patients suffering from active polymyalgia rheumatica/giant cell arteritis (PMR/GCA) prior to steroid treatment. We observed a significant reduction in the absolute number and the relative percentage of CD4-, CD8+ and CD3+, CD16+ and/or CD56+ cells compared to controls. Fifteen patients were investigated prospectively over a 6-month period of prednisone therapy. At the end of the study CD4-CD8+ cells had increased significantly compared to baselines, CD3+ CD16+ and/or CD56+ cells remained significantly lower when compared to controls. We did not observe any abnormalities in the absolute number and percentage of HLA-DR+ T lymphocytes, CD5+ B cells and NK cell phenotypes before or during steroid treatment. Our study confirms that there was significant increase in the absolute number of CD8+ T cells during steroid treatment in the PMR/GCA patients, but indicates the persistence of an immunological alteration despite the control of disease manifestations.

MeSH terms

  • Aged
  • Aged, 80 and over
  • CD4-CD8 Ratio / drug effects
  • Female
  • Giant Cell Arteritis / blood*
  • Giant Cell Arteritis / drug therapy
  • Giant Cell Arteritis / immunology
  • Humans
  • Leukocyte Count / drug effects
  • Lymphocyte Subsets / immunology
  • Lymphocyte Subsets / pathology*
  • Male
  • Middle Aged
  • Polymyalgia Rheumatica / blood*
  • Polymyalgia Rheumatica / drug therapy
  • Polymyalgia Rheumatica / immunology
  • Prednisone / therapeutic use*
  • Prospective Studies

Substances

  • Prednisone